Navigation Links
Wockhardt acquires Protinex, Farex brands from Netherland Co

Indian drug maker, Wockhardt Ltd today said it has acquired Dumex India Pvt Ltd along with its two products Protinex and Farex// from the Netherlands-based Royal Numico NV for an undisclosed sum.

The company plans to change the acquired company's name to 'Dumex' within six months, Wockhardt informed the Bombay stock Exchange.

"Acquisition of Protinex and Farex is a critical milestone in our growth plans in nutrition business. Today's acquisition makes us the undisputed leader in medical nutrition. The global market for medical nutrition is worth USD 32.5 billion," Wockhardt Chairman Habil Khorakiwala said.

Under the agreement, Royal Numico would also offer technical know-how to the company for the manufacture of specialised sugar-free infant food products currently marketed in India and internationally, under its brand names Dulac and Dupro.

The acquisition has the potential to double its nutrition products sale to Rs 120 crore as Protinex and Farex complements its product range, it added.

The company would inherit a strong sales and marketing organisation with 235 personnel and the acquisition follows Royal Numico's decision to focus on China and other markets.

The company has a strong presence in infant nutrition with Dexolac, Nusobee and Firstfood brands, with annual sales of ab out Rs 60 crore.

The company is also in talks with global companies for in-licen sing medical nutrition products.
'"/>




Page: 1

Related medicine news :

1. Wockhardt Group Plans Hospital In Delhi By End-2007
2. Biovac, Hepatitis A Vaccine Marketed By Wockhardt
3. Indias Wockhardt Acquires Irish Firm
4. Mercy killing for newborn with incurable disease in Netherlands
5. Netherlands to lift livestock restrictions over avian influenza
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... 27, 2016 , ... "FCPX editors can now reveal their media with growing ... said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color brings ... users can now reveal the media of their split screens with growing colorful panels. ...
(Date:6/27/2016)... , ... June 27, 2016 , ... TopConsumerReviews.com recently awarded ... Eyeglasses . , Millions of individuals in the United States and Canada wear ... a way to both correct vision and make a fashion statement. Even celebrities use ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... PawPaws ... a new product that was developed to enhance the health of felines. The formula ... , The two main herbs in the PawPaws Cat Kidney Support Supplement ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Key Pharma News Issue 52" report to their offering. ... need in influenza treatment creates a favourable commercial environment for ... and growing patient base that will serve to drive considerable ... flu vaccine would serve to cap sales considerably, but development ...
Breaking Medicine Technology: